Today the Council adopted a regulation which extends the deadline for the certification of medical devices. This measure aims to prevent that medical devices which cannot be certified by the initial cut-off date become unavailable for European patients.
Today we have agreed on measures that will allow the industry to continue bringing essential medical devices to the market and ensure that patients have safe access to medical devices.
Acko Ankarberg Johansson, Swedish minister for health care
A staggered and conditional extension
Producers of medical devices will now have until 31 December 2027 for higher risk devices and until 31 December 2028 for medium and lower risk devices to meet the legal requirements.
The extension of the transition period will be granted under certain conditions. These ensure that only devices that are safe and for which manufacturers have already started the certification procedure will benefit from the additional time.
Removal of “sell-off” date
The regulation adopted today also reduces the risk of medical devices shortages by removing the “sell-off” date rule. The “sell-off” date is the end date after which devices already on the market but not yet with the final user should be withdrawn. Only devices that comply with the previous EU law on medical devices will benefit from this rule. Removing the “sell-off” date will allow safe medical devices to remain longer on the market.
Background and next steps
In April 2017, the Council and the European Parliament adopted two regulations to improve the safety of medical devices and in vitro diagnostic medical devices. Medical devices cover a broad array of products, ranging from hearing devices and wheelchairs to catheters and orthopaedic implants. One of the measures of the 2017 regulation is a more robust conformity assessment system of medical devices. The amending regulation adopted today does not change the requirements of the original regulations of 2017.
Under this system, by the end of the foreseen transition period of 26 May 2024, all medical devices have to conform with the new rules. But because, among other things, conformity assessment bodies suffer from capacity problems to (re)certify old and new medical devices there is a risk that at the end of the transition period a large share of devices will no longer be available to EU patients.
The decision to extend the implementation period will enter into force on the day of its publication in the Official Journal of the EU.
Africa CDC, Institut Pasteur de Dakar (IPD) and the South African Medical Exploration Council (SAMRC) are co-internet hosting the first Biomanufacturing Workforce Progress workshop in Africa.
Around 30 lover organisations will lead to being familiar with the landscape of biomanufacturing instruction, gaps and chances for setting up a gifted and competent workforce on the continent to produce higher vaccine provide resilience for Africa.
La Pointe Sarène, Senegal 07/02/2022 Around 30 spouse organisations will be part of from 7th to 9th February to participate in the to start with Biomanufacturing Workforce Enhancement workshop co-hosted by Africa CDC, IPD and SAMRC.
The Africa CDC has established the formidable target to manufacture 60{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the vaccine doses expected on the continent by 2040. Still, Africa currently only creates about .1{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the worldwide offer of vaccines. In achieving this eyesight of building bigger vaccine supply resilience for Africa, important investments want to be made to build a experienced workforce for deployment in the investigation, improvement and manufacturing marketplace. Current estimates by the Africa CDC expose that involving 6000 and 7000 qualified careers will will need to be made in Africa by 2030 for the vary of needs of the vaccine manufacturing industry by itself.
In this context, the Africa CDC, IPD and SAMRC are signing up for forces to entirely recognize the capability building demands and ambitions in Africa, to get the complete photograph of schooling initiatives obtainable locally, regionally and globally, and identify gaps and possibilities.
This quite practical workshop will end result in concrete roadmaps to achieve aims in the room of biomanufacturing workforce improvement, it will also handle how to create a favourable ecosystem for scalable and sustainable funding of coaching programmes in Africa and the most effective design of partnerships and governance to achieve the continental ambition.
This function also launches the IPD biomanufacturing human funds improvement initiative Expertise & Workforce for Africa Manufacturing’s Fairness (KWAME), which is intrinsically joined to the MADIBA challenge to manufacture and supply significant-good quality, economical and appropriate vaccines for Africa in Senegal.
“As Africa CDC, we perspective this workshop, which provides stakeholders collaborating in developing expertise for Biopharmaceutical manufacturing in Africa, as crucial. The want to understand the roles of all the stakeholders is cardinal for optimum resource utilisation and effective coordination as outlined in the continental Framework for Motion for vaccine production,” reported Dr Ahmed Ouma Ogwell, Ag. Director of Africa CDC.
“Today, far more than 60{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of Africa’s population is below 25 and young Africans are anticipated to constitute 42{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of global youth by 2030. These youthful males and women of all ages are incredibly beneficial property for the continent, and we have a excellent prospect to establish this human money these days to develop a thriving new sector in Africa relying on its possess skills tomorrow. A single of the key aims of KWAME is to ‘accelerate the advancement of a workforce that is formally experienced in Africa by means of collaborations with African nations and manufacturers and with a extended-phrase eyesight at the degree of the higher schooling system to assistance production projects on the continent’. This will not be achievable without the need of robust partnerships, and I am therefore delighted that so lots of of our companions have dedicated to contributing to this 3-working day workshop.” Mentioned Dr Amadou Alpha Sall, CEO of the Institut Pasteur de Dakar
“Building a workforce in Africa is a fundamental component of fantastic great importance. We merely are not able to seek out to manufacture biopharmaceuticals without the need of establishing a skilled workforce for the future. We are delighted to be section of this workshop and share our experiences with the Chan- Shortly-Shiong Family Foundation SAMRC Scholarship plans and training collaborations with international companions. We are in search of to make very long-lasting collaborative methods to this obstacle.” Prof Richard Gordon, Director of Worldwide Business enterprise Improvement for the South African Professional medical Analysis Council.
***********
About Africa CDC
The Africa Centres for Ailment Handle and Prevention (Africa CDC) is a continental autonomous General public Wellbeing company of the African Union which supports Member States in their attempts to bolster overall health techniques and increase surveillance, crisis response, prevention and handle of conditions.
For far more info, go to https://africacdc.org/
About IPD
The Institut Pasteur de Dakar (IPD) is a Senegalese private foundation in the public fascination with the mission to progress community wellbeing and wellbeing in Africa by conducting exploration, providing coaching and training, sharing scientific knowledge, and advancing biotechnology. Considering the fact that its founding in 1896, IPD has been at the forefront of the battle versus infectious illnesses in West Africa. IPD is one of the four WHO prequalified producers to offer yellow fever vaccine to UN’s Businesses. Important funders for MADIBA involve the European Union, the European Expense Bank, the Agence Française de Développement, the Islamic Progress Financial institution, the Global Finance Company, the U.S. Worldwide Enhancement Finance Company, the German Governing administration, and the Federal government of Senegal.
Abide by IPD by way of @PasteurDakar and LinkedIn.
About SAMRC
The South African Medical Investigate Council (SAMRC) was proven in 1969 with a mandate to boost the health of the country’s population, via investigate, development and technological innovation transfer, so that men and women can delight in a far better good quality of lifetime. The scope of the organisation’s investigate projects involves tuberculosis, HIV/AIDS, cardiovascular and non-communicable health conditions, gender and wellness, and liquor and other drug abuse.
